Watch Ticker

GRIFOLS SA S/ADR

Go to GRIFOLS SA S/ADR Website

$7.49

(%)

Live

Previous Close

$7.485

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$ USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

None

GRIFOLS SA S/ADR...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Biocryst Pharmaceuticals - BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December

BioCryst Pharmaceuticals announced that Charlie Gayer will succeed Jon Stonehouse as CEO, effective January 1, 2026, after a successful commercial launch of ORLADEYO and driving significant revenue growth.

Related tickers: BCRX, GIKLY.

Read Full Article

N/A - XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology

XL-protein, a biotech company, has granted Grifols, a global healthcare company, a worldwide license to develop a biopharmaceutical using XL-protein's proprietary PASylation® technology. The collaboration aims to enhance the pharmacological properties of Grifols' therapeutics.

Related tickers: GIKLY.

Read Full Article

Trending Tickers

Please sign in to view